Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan · Delayed Price · Currency is TWD 25.85
0.00 (0.00%)
At close: Mar 24, 2026
Formosa Pharmaceuticals Market Cap
Formosa Pharmaceuticals has a market cap or net worth of 3.9 billion as of March 24, 2026. Its market cap has decreased by -29.47% in one year.
Market Cap
3.90B
Enterprise Value
2.49B
Revenue
9.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.85
Market Cap Chart
Since October 7, 2021, Formosa Pharmaceuticals's market cap has decreased from 5.53B to 3.90B, a decrease of -29.48%. That is a compound annual growth rate of -7.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 3.90B | -2.08% |
| Dec 31, 2025 | 3.99B | -29.51% |
| Dec 31, 2024 | 5.65B | -15.62% |
| Dec 29, 2023 | 6.70B | 13.17% |
| Dec 30, 2022 | 5.92B | 74.66% |
| Dec 30, 2021 | 3.39B | -38.75% |
| Oct 7, 2021 | 5.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Locus Cell | 4.96B |
| Senhwa Biosciences | 4.84B |
| Medigen Biotechnology | 4.63B |
| BioGend Therapeutics | 4.20B |
| Energenesis Biomedical CO.,LTD. | 3.94B |
| ACRO Biomedical | 3.78B |
| Sagittarius Life Science | 3.53B |
| Genovate Biotechnology | 3.45B |